PRO-DEX, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
PRO-DEX, INC. (PDEX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$12.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-09-03
- PRO-DEX, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$948.00K.
- PRO-DEX, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $682.00K.
- PRO-DEX, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $266.00K, a 89.15% decline year-over-year.
- PRO-DEX, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$12.00K, a 102.07% decline year-over-year.
- PRO-DEX, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2026 was -$12.00K, a 106.70% decline from fiscal 2025.
- PRO-DEX, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $179.00K, a 92.65% decline from fiscal 2024.
- PRO-DEX, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $2.44M.
- PRO-DEX, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$1.15M, a 157.91% decline from fiscal 2022.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$948.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-03 | -$266.00K derived: sum of 2 quarters · filed 2026-09-03 | $0.00 derived: sum of 3 quarters · filed 2026-09-03 | -$12.00K 10-K · filed 2026-09-03 |
| 2026-03-31 | $682.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-30 | $948.00K derived: sum of 2 quarters · filed 2026-04-30 | $936.00K 10-Q · filed 2026-04-30 | -$486.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-12-31 | $266.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-29 | $254.00K 10-Q · filed 2026-01-29 | -$1.17M derived: sum of 3 quarters · filed 2026-09-03 | -$2.60M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-09-30 | -$12.00K 10-Q · filed 2025-10-30 | -$1.43M derived: sum of 2 quarters · filed 2026-09-03 | -$2.86M derived: sum of 3 quarters · filed 2026-09-03 | -$412.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-06-30 | -$1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-03 | -$2.85M derived: sum of 2 quarters · filed 2026-09-03 | -$400.00K derived: sum of 3 quarters · filed 2026-09-03 | $179.00K 10-K · filed 2026-09-03 |
| 2025-03-31 | -$1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-30 | $1.02M derived: sum of 2 quarters · filed 2026-04-30 | $1.60M 10-Q · filed 2026-04-30 | $3.33M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-29 | $3.03M 10-Q · filed 2026-01-29 | $4.76M derived: sum of 3 quarters · filed 2026-01-29 | $5.13M derived: sum of 4 quarters · filed 2026-01-29 |
| 2024-09-30 | $579.00K 10-Q · filed 2025-10-30 | $2.31M derived: sum of 2 quarters · filed 2025-10-30 | $2.67M derived: sum of 3 quarters · filed 2025-10-30 | $2.98M derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-04 | $2.10M derived: sum of 2 quarters · filed 2025-09-04 | $2.40M derived: sum of 3 quarters · filed 2025-09-04 | $2.44M 10-K · filed 2025-09-04 |
| 2024-03-31 | $370.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-01 | $675.00K derived: sum of 2 quarters · filed 2025-05-01 | $710.00K 10-Q · filed 2025-05-01 | $604.00K derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $305.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-30 | $340.00K 10-Q · filed 2025-01-30 | $234.00K derived: sum of 3 quarters · filed 2025-01-30 | -$960.00K derived: sum of 4 quarters · filed 2025-01-30 |
| 2023-09-30 | $35.00K 10-Q · filed 2024-10-31 | -$71.00K derived: sum of 2 quarters · filed 2024-10-31 | -$1.26M derived: sum of 3 quarters · filed 2024-10-31 | -$1.39M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | -$106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-05 | -$1.30M derived: sum of 2 quarters · filed 2024-09-05 | -$1.43M derived: sum of 3 quarters · filed 2024-09-05 | -$1.15M 10-K · filed 2024-09-05 |
| 2023-03-31 | -$1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-02 | -$1.32M derived: sum of 2 quarters · filed 2024-05-02 | -$1.05M 10-Q · filed 2024-05-02 | $271.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | -$126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-08 | $147.00K 10-Q · filed 2024-02-08 | $1.47M derived: sum of 3 quarters · filed 2024-02-08 | $2.51M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | $273.00K 10-Q · filed 2023-11-02 | $1.59M derived: sum of 2 quarters · filed 2023-11-02 | $2.64M derived: sum of 3 quarters · filed 2023-11-02 | $2.09M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-13 | $2.37M derived: sum of 2 quarters · filed 2023-10-13 | $1.81M derived: sum of 3 quarters · filed 2023-10-13 | $1.99M 10-K · filed 2023-10-13 |
| 2022-03-31 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-04 | $496.00K derived: sum of 2 quarters · filed 2023-05-04 | $673.00K 10-Q · filed 2023-05-04 | -$14.00K derived: sum of 4 quarters · filed 2023-10-13 |
| 2021-12-31 | -$553.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-02 | -$376.00K 10-Q · filed 2023-02-02 | -$1.06M derived: sum of 3 quarters · filed 2023-10-13 | -$161.00K derived: sum of 4 quarters · filed 2023-10-13 |
| 2021-09-30 | $177.00K 10-Q · filed 2022-11-03 | -$510.00K derived: sum of 2 quarters · filed 2023-10-13 | $392.00K derived: sum of 3 quarters · filed 2023-10-13 | $1.05M derived: sum of 4 quarters · filed 2023-10-13 |
| 2021-06-30 | -$687.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-13 | $215.00K derived: sum of 2 quarters · filed 2023-10-13 | $872.00K derived: sum of 3 quarters · filed 2023-10-13 | $105.00K 10-K · filed 2023-10-13 |
| 2021-03-31 | $902.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-05 | $1.56M derived: sum of 2 quarters · filed 2022-05-05 | $792.00K 10-Q · filed 2022-05-05 | |
| 2020-12-31 | $657.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-03 | -$110.00K 10-Q · filed 2022-02-03 | ||
| 2020-09-30 | -$767.00K 10-Q · filed 2021-11-15 | |||
| 2020-03-31 | $470.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-06 | $739.00K derived: sum of 2 quarters · filed 2021-05-06 | -$301.00K 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-04 | -$771.00K 10-Q · filed 2021-02-04 | ||
| 2019-09-30 | -$1.04M 10-Q · filed 2020-11-05 | |||
| 2019-03-31 | $654.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-07 | $435.00K derived: sum of 2 quarters · filed 2020-05-07 | $353.00K 10-Q · filed 2020-05-07 | |
| 2018-12-31 | -$219.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | -$301.00K 10-Q · filed 2020-02-06 | ||
| 2018-09-30 | -$82.00K 10-Q · filed 2019-11-07 | |||
| 2013-03-31 | $610.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-13 | -$377.00K derived: sum of 2 quarters · filed 2013-05-13 | $134.00K 10-Q · filed 2013-05-13 | -$834.00K derived: sum of 4 quarters · filed 2013-05-13 |
| 2012-12-31 | -$987.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-13 | -$476.00K 10-Q · filed 2013-02-13 | -$1.44M derived: sum of 3 quarters · filed 2013-02-13 | -$1.79M derived: sum of 4 quarters · filed 2013-05-13 |
| 2012-09-30 | $511.00K 10-Q · filed 2012-11-08 | -$457.00K derived: sum of 2 quarters · filed 2012-11-08 | -$799.00K derived: sum of 3 quarters · filed 2013-05-13 | -$396.00K derived: sum of 4 quarters · filed 2013-05-13 |
| 2012-06-30 | -$968.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-12 | -$1.31M derived: sum of 2 quarters · filed 2013-05-13 | -$907.00K derived: sum of 3 quarters · filed 2013-05-13 | -$1.52M 10-K · filed 2012-09-12 |
| 2012-03-31 | -$342.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-13 | $61.00K derived: sum of 2 quarters · filed 2013-05-13 | -$555.00K 10-Q · filed 2013-05-13 | -$338.00K derived: sum of 4 quarters · filed 2013-05-13 |
| 2011-12-31 | $403.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-13 | -$213.00K 10-Q · filed 2013-02-13 | $4.00K derived: sum of 3 quarters · filed 2013-02-13 | $767.00K derived: sum of 4 quarters · filed 2013-02-13 |
| 2011-09-30 | -$616.00K 10-Q · filed 2012-11-08 | -$399.00K derived: sum of 2 quarters · filed 2012-11-08 | $364.00K derived: sum of 3 quarters · filed 2012-11-08 | -$815.00K derived: sum of 4 quarters · filed 2012-11-08 |
| 2011-06-30 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-12 | $980.00K derived: sum of 2 quarters · filed 2012-09-12 | -$199.00K derived: sum of 3 quarters · filed 2012-09-12 | $383.00K 10-K · filed 2012-09-12 |
| 2011-03-31 | $763.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10 | -$416.00K derived: sum of 2 quarters · filed 2012-05-10 | $166.00K 10-Q · filed 2012-05-10 | |
| 2010-12-31 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-07 | -$597.00K 10-Q · filed 2012-02-07 | ||
| 2010-09-30 | $582.00K 10-Q · filed 2011-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |